6QG4

Target information

RCSB PDB
6QG4
Title
Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine inhibitor 1h
Method
X-RAY DIFFRACTION
Resolution
2.3
Classification
TRANSFERASE
Organism
Homo sapiens
Protein
Dual specificity mitogen-activated protein kinase kinase 7 (O14733)    Looking for covalent inhibitors of this target ?
Year
2019
Publication Title
Characterization of Covalent Pyrazolopyrimidine-MKK7 Complexes and a Report on a Unique DFG-in/Leu-in Conformation of Mitogen-Activated Protein Kinase Kinase 7 (MKK7).
Abstract

Pyrazolopyrimidines are well-established as covalent inhibitors of protein kinases such as the epidermal growth factor receptor or Bruton's tyrosine kinase, and we recently described their potential in targeting mitogen-activated protein kinase kinase 7 (MKK7). Herein, we report the structure-activity relationship of pyrazolopyrimidine-based MKK7 inhibitors and solved several complex crystal structures to gain insights into their binding mode. In addition, we present two structures of apo-MKK7, exhibiting a DFG-out and an unprecedented DFG-in/Leu-in conformation.

External Link
RCSB PDB





Ligand information

HET
J0E
Chain ID
A
HET Number
501
Molecular Formula
C19H20N6O2
Structure
2D structure
IUPAC Name
1-[(3R)-3-[4-amino-3-(4-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidyl]prop-2-en-1-one
InChI
InChI=1S/C19H20N6O2/c1-2-15(27)24-9-3-4-13(10-24)25-19-16(18(20)21-11-22-19)17(23-25)12-5-7-14(26)8-6-12/h2,5-8,11,13,26H,1,3-4,9-10H2,(H2,20,21,22)/t13-/m1/s1
InChI Key
VRKPYFGIHAMROD-CYBMUJFWSA-N
Canonical SMILES
Oc1ccc(cc1)-c2nn(c(c23)ncnc3N)[C@@H]4CCCN(C4)C(=O)C=C
Bioactivity data
CI003845

Covalent Binding

Warhead
Michael Acceptor
Reaction Mechanism
Michael Addition
Residue
CYS : 218
Residue Chain
A
Interactions
Pharmacophore Model